Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07670156 Upadacitinib hemihydrate Job Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07670156 clinical trial report covering Upadacitinib hemihydrate, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
ChiCTR2600127270 Trastuzumab Rezetecan Solid tumor Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
ChiCTR2600127270 clinical trial report covering Trastuzumab Rezetecan, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space
Read →
Latest Hotspot
8 min read
NCT07673809 GNR-097 Muscular Dystrophy, Duchenne Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07673809 clinical trial report covering GNR-097, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07674667 UNC13A program(Trace Neuroscience) Amyotrophic Lateral Sclerosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07674667 clinical trial report covering UNC13A program(Trace Neuroscience), Phase 1/2, endpoints, sponsor, geography, readout timing and development whi
Read →
Latest Hotspot
8 min read
CTR20262408 Human Cord derived MSC(Tianjin Amcellgene Engineering) Refractory Acute Graft Versus Host Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262408 clinical trial report covering Human Cord derived MSC(Tianjin Amcellgene Engineering), Phase 1/2, endpoints, sponsor, geography, readout timing
Read →
Latest Hotspot
8 min read
NCT07675174 Sitagliptin Phosphate Graft vs Host Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07675174 clinical trial report covering Sitagliptin Phosphate, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
CTR20262489 Albumin-Bound Paclitaxel Non-Small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262489 clinical trial report covering Albumin-Bound Paclitaxel, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
CTR20262448 ANS-02 EGFR-mutated non-small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262448 clinical trial report covering ANS-02, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07679841 Nivolumab Squamous cell carcinoma of vulva Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07679841 clinical trial report covering Nivolumab, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07679542 Artenimol Metabolic Dysfunction Associated Steatohepatitis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07679542 clinical trial report covering Artenimol, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07678593 Cetuximab Pancreatic Ductal Adenocarcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07678593 clinical trial report covering Cetuximab, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07680595 Folic Acid Carotid Artery Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07680595 clinical trial report covering Folic Acid, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
<
1
<<
998
999
1000
1001
1002
>>
2260
>